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O B J E C T I V E S The purpose of this study was to validate T2*-weighted cardiac magnetic resonance
(T2*-CMR) for the detection and quantiﬁcation of reperfusion hemorrhage in vivo against an ex vivo gold
standard, and to investigate the relationship of hemorrhage to microvascular obstruction, infarct size,
and left ventricular (LV) functional parameters.
B A C KG ROUND Hemorrhage can contribute to reperfusion injury in myocardial infarction and
may have signiﬁcant implications for patient management. There is currently no validated imaging
method to assess reperfusion hemorrhage in vivo. T2*-CMR appears suitable because it can create
image contrast on the basis of magnetic ﬁeld effects of hemoglobin degradation products.
METHOD S In 14 mongrel dogs, myocardial infarction was experimentally induced. On day 3
post-reperfusion, an in vivo CMR study was performed including a T2*-weighted gradient-echo imaging
sequence for hemorrhage, standard sequences for LV function, and post-contrast sequences for
microvascular obstruction and myocardial necrosis. Ex vivo, thioﬂavin S imaging and triphenyl-
tetrazoliumchloride (TTC) staining were performed to assess microvascular obstruction, hemorrhage,
and myocardial necrosis. Images were analyzed by blinded observers, and comparative statistics were
performed.
R E S U L T S Hemorrhage occurred only in the dogs with the largest infarctions and the greatest extent
of microvascular obstruction, and it was associated with more compromised LV functional parameters.
Of 40 hemorrhagic segments on TTC staining, 37 (92.5%) were positive for hemorrhage on T2*-CMR
(kappa  0.96, p  0.01 for in vivo/ex vivo segmental agreement). The amount of hemorrhage in 13
affected tissue slices as determined by T2*-CMR in vivo correlated strongly with ex vivo results (20.3 
2.3% vs. 17.9  1.6% per slice; Pearson r  0.91; r2  0.83, p  0.01 for both). Hemorrhage size was not
different between in vivo T2*-CMR and ex vivo TTC (mean difference 2.39  1.43%; p  0.19).
CONC L U S I O N S T2*-CMR accurately quantiﬁed myocardial reperfusion hemorrhage in vivo.
Hemorrhage was associated with more severe infarct-related injury. (J Am Coll Cardiol Img 2011;4:
1274–83) © 2011 by the American College of Cardiology Foundation
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1275T
he success of reperfusion therapy in ST-
elevation myocardial infarction is often di-
minished by a persistent post-procedural re-
duction of tissue perfusion at a microvascular
evel (1,2). This phenomenon related to reperfusion
njury is characterized by 2 major components:
icrovascular obstruction (MO) and reperfusion
emorrhage.
MO was first described in the myocardium by
loner et al. (3) and has since been investigated in
atients with several imaging modalities (e.g.,
hrombolysis In Myocardial Infarction flow or
rame count [4–6], myocardial blush grade [5],
oronary Doppler imaging [7], contrast echocardi-
graphy [8,9], and contrast-enhanced cardiac mag-
etic resonance [CMR] [2,10,11]). It was consis-
ently associated with an adverse outcome for
atients, including impaired functional recovery
nd increased mortality (1,2,12–17).
In contrast to MO, there is no validated imaging
ethod for reperfusion hemorrhage in vivo, and
herefore the specific role of hemorrhage as a
ontributor to reperfusion injury in humans remains
ll-defined.
In images acquired by T2*-weighted magnetic
esonance sequences, the regional signal intensity
SI) drops in hemorrhagic tissue because of altered
olecular magnetic properties of hemoglobin deg-
adation products (18,19). T2*-weighted imaging
as become a clinical standard in the evaluation of
emorrhagic stroke (20–22), and initial reports for
maging myocardial hemorrhage in patients dem-
nstrated feasibility for cardiac imaging (23). How-
ver, validation of T2*-weighted CMR (T2*-
MR) for myocardial hemorrhage using an ex vivo
old standard has yet to be performed, and there-
ore the diagnostic accuracy remains unclear.
The primary aim of this study was to validate the
ccuracy of T2*-CMR for the detection of isch-
mia/reperfusion injury–related myocardial hemor-
hage in canines in vivo, when compared to ex vivo
athology. As a secondary goal, we also investigated
he relationship of hemorrhage to MO, infarct size,
entricular volumes, and function.
M E T H O D S
Animal model of reperfused myocardial infarction.
The animal study was performed in 14 female
mongrel dogs (weight 19 to 23 kg). The study was
approved by the University of Western Ontario
Council on Animal Care (Animal Use Sub-
committee).After 12 h of fasting, the dogs were anesthetized,
intubated, and ventilated. Fentanyl citrate at 20 to
50 g  h/kg was maintained for pain control;
electrocardiogram (ECG) and blood pressure were
monitored. Ventricular arrhythmia was controlled
by boluses of lidocaine 1 mg/kg. After open thora-
cotomy, the left anterior descending coronary artery
was ligated distal to the first diagonal branch for 3
to 4 h. The pericardium was reapproximated, and
the chest closed. The dogs were extubated and
allowed to recover; pain was controlled with a
fentanyl patch for 48 h. At day 3 post–reperfused
myocardial infarction, an in vivo CMR study and an
ex vivo pathology study were performed.
In vivo CMR. CMR was performed on a 1.5-T
ystem (Magnetom Avanto, Siemens Healthcare,
rlangen, Germany) using a 6-channel, phased-
rray cardiac coil (body coil for T2* acquisitions),
nder anesthesia and intubation/ventilation. All
mages were acquired using ECG triggering and
pplying breath-hold maneuvers by halt-
ng the ventilator for the time of image
cquisition. The animals’ heart rates were
etween 90 and 115 min1, and breath-
hold durations were 18 s for all CMR
image acquisitions.
After standard localization sequences,
the following CMR sequences were ap-
plied in short-axis views, with a slice
thickness of 10 mm with 0 gap, covering
the entire left ventricle. For ventricular
volumes and function, a steady-state free-
precession (SSFP) sequence was used. For
imaging myocardial hemorrhage, using the body
coil, and after regional shimming, we applied a
T2*-weighted gradient echo sequence with echo-
planar readout, flip angle of 90°, effective echo time
of 35 ms, ECG-triggered to mid-diastole, acquisi-
tion window of 72 ms, and an echo-planar imaging
factor of 29. The total image data acquisition
required 5 heart beats using a trigger pulse of 1 R-R
interval. Typical values were: field of view, 350 
17 mm; matrix, 256  128; and the resulting
in-plane resolution, 1.4  1.4 mm. Because a body
coil was used for T2*-CMR images, we did not
apply surface coil intensity profile correction or
pre-scan normalization. For visualizing MO, we
used an inversion-recovery gradient echo (IR-GE)
sequence 1.5 to 4 min after injection of 0.1
mmol/kg body weight of gadolinium-DTPA
(Magnevist, Bayer Health Care, Toronto, Ontario,
Canada) (2). For assessing myocardial necrosis, the
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1276contrast injection, with an inversion time optimized
to null signal from remote myocardium (late gado-
linium enhancement) (24,25).
CMR image analysis. CMR images of a given se-
uence were analyzed by an observer blinded to the
esults of the other sequences and blinded to ex vivo
mages using certified software (cmr42, Circle CVI,
algary, Alberta, Canada). A standard slice-
ummation method was used to analyze SSFP cine
mages for left ventricular (LV) volumes and func-
ion. For tissue characterization, a semiautomated
hreshold-based detection method was used: Endo-
ardial and epicardial borders were traced manually,
nd a region of interest was drawn in the myocar-
ium opposite the infarcted area in the inferior wall.
n the T2* and early post-contrast IR-GE images,
he software automatically displayed areas of hem-
rrhage and MO, as defined by a SI of 2 SDs
elow the mean SI of remote tissue. A threshold of
5 SDs above the mean of remote myocardium was
pplied for late enhancement images (26,27). The
olumetric extent of pathological tissue was mea-
ured. In addition, segmental involvement of hem-
rrhage was assessed using 6 segments per slice.
he amount of hemorrhage was also measured as a
ercentage per slice for comparison with ex vivo
ata.
Image contrast was calculated using the follow-
ng formula: Contrast  [(SIremote myocardium –
SIhemorrhagic myocardium)/SIremote myocardium 100%] (28).
Susceptibility artifacts on T2*-CMR were de-
fined a priori as areas of reduced or increased signal,
which crossed anatomical borders, included the
epicardial surface at the interface of myocardium,
pericardium, and surrounding tissues, and could not
be explained by adjacent anatomy (29,30) (Fig. 1).
All artifacts were registered but excluded from the
analysis of hemorrhage.
Ex vivo studies. After the CMR study, the dogs were
maintained in general anesthesia, the chest was re-
opened, and 20 ml of a 4% thioflavin S solution was
injected into the left atrium for subsequent imaging of
MO. The dogs were euthanized, the hearts excised,
and the myocardium was sectioned into short-axis
slices of 10-mm thickness. Thioflavin S imaging for
MO was performed using a digital camera with a
band-pass filter for fluorescent signal. Thioflavin S
stains endothelium in perfused blood vessels, and
myocardium subject to MO remains unstained
(31,32). Subsequently, triphenyl-tetrazolium chloride
(TTC) staining was performed for hemorrhage and
necrosis. TTC stains healthy myocardium brick red.
Necrotic myocardium is not stained and appearspale white; hemorrhage within the necrosis zone
appears dark red (32–34). The slices were digitally
photographed.
Images of thioflavin S and TTC-stained slices
were quantified using digital image analysis soft-
ware (35). After careful optimization of image
display for contrast and brightness, and enlarging
the size for optimal visualization of tissue pathol-
ogy, regions of interest were drawn manually in
software using a contour tool, delineating tissue
pathology (MO on thioflavin S images, necrosis
and hemorrhage on TTC images). Areas of pathol-
ogy were measured for each slice as percentage of all
pixels representative of myocardium.
Before analysis, one observer matched in vivo and
ex vivo image slices to be compared, using slice
position information and anatomical landmarks.
This observer was subsequently blinded by not
having access to the data for 2 months.
Comparative assessment of tissue pathology. Using
the methods described here, in vivo measurements
of hemorrhage on T2*-CMR were compared with
ex vivo hemorrhage on TTC images for segmental
involvement and for percent myocardium involved
per slice. The different tissue pathologies of MO,
hemorrhage, and necrosis were compared with re-
gard to their relative extent and involvement of total
myocardium, and LV functional and volumetric
data were compared for groups expressing different
combinations of tissue pathology.
Clinical translation. To gain a preliminary impression
of potential clinical applicability, we applied a similar
imaging protocol using T2*-CMR in a small cohort of
patients (n  5) with late reperfused MI. Because of
the small sample, results were not systematically
analyzed.
Statistics. Data are expressed as mean  SE. Seg-
mental involvement of hemorrhage was compared
in vivo and ex vivo using kappa agreement statistics.
For assessing the relationship between continuous
variables, Pearson correlation coefficient and linear
regression analysis were performed. Differences be-
tween in vivo and ex vivo measurements were
analyzed with a Bland-Altman plot. A Kolmogorov-
Smirnov test was used to test the normal distribution
of data. To compare continuous variables, a Student
t test or Mann-Whitney U test was used, depending
on the distribution of data. Multiplicity correction
was not performed, but the analysis of hemorrhage
size took into consideration that image slices with
hemorrhage were not independent but originated
from a limited number of animals.
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1277R E S U L T S
From 14 dogs examined, 1 lacked detectable necro-
Figure 1. Corresponding Images of Short Axis Slice From One (
and 4 Dogs With Hemorrhagic Infarction
On the triphenyl-tetrazolium chloride (TTC) stain, a large anterior an
is pale without evidence of hemorrhage in the upper panels, while
slice in the lower panels (images on the very left; black arrows). T
signal without evidence for a perfusion abnormality in most of the
endocardium/mid-myocardium of the anterior/lateral walls, consiste
T2*-cardiac magnetic resonance (CMR) images for hemorrhage show
hemorrhagic infarction (upper panels), but a signal decrease reﬂec
panels 2–5). Occasional susceptibility artifacts lead to a signal decr
gadolinium-enhanced image.sis on both late enhancement and TTC imagingand was excluded from the analysis. Thirteen dogs
were available for analysis, and all demonstrated
evidence of myocardial necrosis. Those were di-
Panel) Dog With Nonhemorrhagic Infarction
teral myocardial infarct is visible in all cases. The infarcted tissue
hemorrhage is visible in the subendocardium of the TTC-stained
thioﬂavin S images (second from left) show normal ﬂuorescent
cardium, but there is an absence of thioﬂavin S signal in the sub-
ith microvascular obstruction in those areas. The corresponding
homogenous signal without regional signal decrease in the non-
the area of hemorrhage in hemorrhagic infarction (white arrows,
on T2* that crosses anatomical borders (asterisks). LGE  lateTop
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1278without evidence of microvascular injury in vivo and
ex vivo (MO- group). Eight dogs had MO on both
early post-contrast IR-GE CMR and thioflavin S
imaging: 4 dogs with MO but without reperfusion
hemorrhage (MOH- group) and 4 with MO and
reperfusion hemorrhage (MOH group). No
og had hemorrhage in the absence of MO. Exam-
les of 1 nonhemorrhagic and all hemorrhagic
nfarctions are shown in Figure 1.
Comparison of hemorrhage in vivo versus ex
vivo. Sixty-four slices could be successfully matched
or in vivo/ex vivo comparison: 46 slices showed
e 2. Plot of the Linear Regression Analysis and
-Altman Plot for In Vivo/Ex Vivo Comparison of the Extent of
rfusion Hemorrhage
xtent of hemorrhage was measured as a percentage of total myo-
m per slice. A shows linear regression analysis. The solid lines
e regression line based on the study data and their conﬁdence
; the dotted line represents the reference line of equality (slope 1.0).
vivo T2*-CMR measurement of hemorrhage correlated well with
rrhage on ex vivo TTC staining (r2  0.83; p  0.01). The slope of
gression line is 1.27 (95% conﬁdence interval: 0.98 to 1.56).
ws Bland-Altman plot. In repeated measurements, there was no signiﬁ-
ifference in hemorrhage size (mean difference 2.39%, p  0.194 [95%
ence interval: 2.17 to 6.96]). Abbreviations as in Figure 1.ecrosis on TTC staining, 28 showed MO on (hioflavin S staining, and 13 slices (from 4 dogs)
howed hemorrhage on TTC staining. All slices
ith hemorrhage on TTC staining also had MO on
hioflavin S staining.
The in vivo T2*-weighted CMR sequence
ielded a contrast of 58  19 for hemorrhagic
ersus remote myocardium. Overall, 384 segments
ere available for analysis, but 36 segments (9%)
ere excluded due to image artifacts, leaving 348
egments for analysis. From 40 hemorrhagic seg-
ents on TTC staining, 37 were positive on T2*-
MR. The kappa value for in vivo/ex vivo segmen-
al agreement was 0.96 (p  0.01).
In 13 slices affected by hemorrhage, the mean
emorrhage volume was 20.3  2.3% per slice on
he in vivo T2*-CMR images, and 17.9  1.6% per
lice on ex vivo TTC images. The values correlated
ell (r  0.91; p  0.01). Taking into account
multiple measurements in 4 dogs, there was no
significant difference between the amount of hem-
orrhage: the mean difference between T2*-CMR
and TTC was 2.39  1.43% (p  0.194; 95%
onfidence interval: –2.17 to 6.96) (Fig. 2). The
inear regression analysis yielded r2  0.83 (p 
.01) (Fig. 2A). The slope of the regression curve
as 1.27 (95% confidence interval: 0.98 to 1.56).
Relation of hemorrhage to MO and necrosis CMR
image analysis. Infarct size on late enhancement
CMR in all dogs was 7.9  2.6 g. MO in all dogs
comprised 5.0  1.5 g (8.4  1.3 g in dogs with
hemorrhage), and hemorrhage extent measured 6.1 
0.3 g. The amount of hemorrhage was smaller than
the amount of MO in all dogs (mean difference 2.3 
1.0 g). The extent of necrosis correlated well with
the extent of MO (r  0.77; p  0.05), the extent
of MO correlated well with the extent of hemor-
rhage (r  0.87; p  0.05), and there was a
moderate correlation between the extent of necrosis
and the extent of hemorrhage (r  0.56; p  0.05).
Infarct size was larger in the subgroup with
emorrhage MOH when compared with both
ther subgroups MO- and MOH- (MO- 1.9 
.4 g; MOH- 4.1  1.8 g; MOH 19.3 
4.0 g; p  0.05 for comparison of means of
MOH vs. both other groups [Fig. 3]). The
amount of MO was larger in the group with
hemorrhage than in the nonhemorrhage group
(MOH- 1.6  0.7 g vs. MOH 8.4  1.3 g;
p  0.05 [Fig. 3]). In fact, hemorrhage was con-
ned in this study to the 4 dogs that had both the
argest infarcts and also the largest amount of MOFigur
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1279LV functional data were obtained from all dogs
except for 1 due to an incomplete cine CMR dataset
(hemorrhage group). Mean LV ejection fraction
was lower in dogs with hemorrhage compared with
dogs with MO but without hemorrhage (MOH-
52  7% vs. MOH 28  4%; p  0.05).
ardiac output was lower in dogs with hemorrhage
ompared with dogs with MO but without hemor-
hage (MOH- 2.7  0.2 l min1 vs. MOH
.9  0.1 l min1; p  0.05). Mean LV end-
iastolic volume was 71  13 ml and did not differ
among groups. Mean LV mass in all dogs was 75 
15 g and was higher in the MOH group com-
pared with the combination of the MO- and
MOH- groups (90 13 g vs. 70 12 g; p 0.05).
Ex vivo analysis. The results of the ex vivo analysis
re summarized in Table 1. Infarct-related necrosis
overed a mean of 16.8  2.4% of the myocardium
er slice considering all slices with necrosis. Com-
aring the ex vivo TTC-stained slices according to
he subgroups described earlier, the MO- group
ad less necrosis per slice than the MOH- group,
hich again had less necrosis per slice than the
OH group (mean amount of tissue necrosis
er slice: MO- 5.1 1.6%; MOH- 11.3 1.5%;
OH 38.8  2.8%; p  0.05 for all compar-
sons). For MO, a larger percentage of MO per slice
as observed in slices with hemorrhage (n  13)
ompared with slices without hemorrhage (n  15)
MOH- 7.8  1.4% per slice vs. MOH 27.4 
.3% per slice; p  0.0001). Hemorrhage occupied
mean of 17.9  1.6% of myocardium in affected
lices (n  13).
The area of necrosis was consistently larger
han the area of MO (mean difference 7.2  1.3%
f myocardium per slice). The region with MO
as consistently larger than that of hemorrhage
mean difference 8.8  2.0% of myocardium per
lice).
Clinical translation. We observed hemorrhage in 3 of
patients with acute myocardial infarction who
eceived reperfusion therapy 8 h after onset of
hest pain. Example images of a patient are pre-
ented in Figure 5.
D I S C U S S I O N
We demonstrated that in vivo T2*-CMR accu-
rately quantifies myocardial hemorrhage post-
reperfusion in acute myocardial infarction com-
pared with an ex vivo gold standard. Hemorrhage
is located in the core of the infarction, mainly
subendocardial, embedded within the zone ofMO. Hemorrhage did not occur without MO,
was associated with larger myocardial infarction,
more extensive MO, and greater reduction of LV
systolic function.
Our data provide the first systematic in vivo/ex
vivo validation of T2*-CMR for the assessment of
reperfusion hemorrhage. There are previous reports
(without in vivo/ex vivo validation) that suggested
the use of T2-weighted spin-echo sequences (36–38)
for detecting hemorrhage.
Although magnetic susceptibility effects stem-
ming from hemoglobin degradation products may
lead to reduced signal in T2 images, the T2* effects
Figure 3. Overview of In Vivo CMR Parameters Divided
According to Subgroups
Dogs with hemorrhage (MOH) had (A) larger infarctions and (B
more MO. Signiﬁcant p values are marked with an asterisk. Values
mean  1 SE. H  reperfusion hemorrhage; MO  microvascular)
areobstruction; other abbreviation as in Figure 1.
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1280are substantially greater. The principal mechanism
augmenting T2* sensitivity to such off-resonance
effects is the absence of any radiofrequency refocus-
ing pulses that lead to an accelerated loss of phase
coherence among spins (39). T2*-CMR was re-
cently applied to assess hemorrhage in patients (23),
but so far there is no in vivo/ex vivo validation
available.
Pathophysiological aspects. Our results provide the
first in vivo confirmation of previous ex vivo
work; earlier ex vivo studies have suggested that
hemorrhage may occur as a complication of MO
(40,41). In line with this observation, we ob-
served in vivo hemorrhage within the MO zone,
and the extent of hemorrhage was smaller than
the extent of MO. Furthermore, few dogs had
MO without hemorrhage.
We observed a linear relationship between the
extent of necrosis, MO, and hemorrhage, suggest-
e 4. Relationship of Hemorrhagic and Nonhemorrhagic
ardial Infarcts to the Amount of MO and Infarct Size as
ured by In Vivo CMR
emorrhagic and nonhemorrhagic groups are distinct, with hemor-
occurring exclusively in the 4 dogs with the largest infarcts as
s the greatest amount of MO. Abbreviations as in Figures 1 and 3.
Table 1. Ex Vivo Imaging Data for Necrosis, Microvascular Obst
All MO-
TTC % necrosis 16.8 2.4 5.1 1.6
Thioﬂavin S % MO —
TTC % hemorrhage —
Values are mean  SD. Hemorrhage was smaller than the amount of MO. In slic
nonhemorrhagic slices. Extent measured as mean percentage per slice  SEM.
MO  microvascular obstruction; NA  not applicable; NS  not signiﬁcant; TTCing that these components of tissue injury are not
independent of each other, and that there could
perhaps be a causal relationship. Hemorrhage oc-
curred only in infarcts with the most extensive MO
and the largest infarct size (both around 4 times
larger than infarcts with MO but without hemor-
rhage), suggesting that the amount and severity of
tissue injury may be a predisposing factor for the
development of hemorrhage. Although CMR al-
ready provides imaging tools for the first 3 major
components of tissue injury (edema [T2-weighted
CMR], cardiomyocyte necrosis [late enhancement
CMR], and MO [early IR-GE CMR]), our data
indicate that T2*-weighted imaging provides an
additional noninvasive imaging tool for the fourth
major component of acute tissue injury, myocardial
hemorrhage.
Imaging aspects. Theoretically, a small overestima-
ion of in vivo hemorrhage measurements with
2*-CMR had been expected, explained by mag-
etic field effects related to hemorrhage exceeding
he spatial extent of hemorrhage. Also, CMR de-
ivers a summation signal from the entire slice
hickness while ex vivo pathology delivers surface
mages. Nevertheless, hemorrhage size did not dif-
er between in vivo and ex vivo measurements when
aking into account multiple measurements in 4
ogs. TTC staining was used here as a reference
tandard for macroscopic hemorrhage, as estab-
ished previously (32,40,41); we did not perform
istology for microscopic hemorrhage. Although
tudies with a larger sample size could help to
etermine potential differences between T2*-CMR
or in vivo hemorrhage and hemorrhage on ex vivo
athology, we expect that those may be small and
erhaps not clinically important because hemor-
hage size was similar by T2* in vivo and ex vivo
TC in this study.
We found a relatively high incidence of arti-
acts (9% of all segments). In our study, these
rtifacts were easy to identify (usually epicardial,
penetrating” anatomical structures) (29,30) and
id not interfere with hemorrhage signal analysis.
ion, and Hemorrhage
MO H- MO H p Value
11.3 1.5 38.8 2.8 0.05 for all subgroups
7.8 1.4 27.4 2.3 0.0001
— 17.9 1.6 NA
ith hemorrhage, there was a greater extent of MO and necrosis compared withFigur
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1281Theoretically, a problem could occur in a very
large myocardial infarction with transmural hem-
orrhage fusing with an epicardial susceptibility
artifact that accidentally occurs in the same seg-
ment. We did not encounter this scenario in our
study.
Finally, it has to be expected that advances in
sequence development (e.g., T2*-prepared SSFP
sequences, T2* mapping) will be able to reduce
image artifacts while maintaining sufficient T2*
sensitivity for imaging hemorrhage in the future.
Clinical implications. This approach provides
means to shed light on myocardial hemorrhage as
a complication of ischemia/reperfusion injury in
acute myocardial infarction. The implications of
hemorrhage, including its incidence, possible ad-
verse effects on LV remodeling, and patient
prognosis, can now be studied in patients without
the use of a contrast agent. The protective or
facilitating effects of drugs such as thrombolytic
agents, anticoagulants, and platelet aggregation
inhibitors on myocardial hemorrhage may now be
investigated using T2*-weighted CMR in
patients.
Although LV systolic function was most com-
Figure 5. Midventricular Short-Axis Views of a Patient With Lat
(Upper panel) Short-axis cine snapshots of an end-diastolic and en
extreme left) Pre-contrast T2-STIR imaging showing high signal in t
Post-contrast (10 min) LGE showing a nearly transmural anterosepta
contrast injection (2 to 3 min) reveals a large area of microvascular ob
area of subendocardial low signal within the microvascular obstruction
ent echo with echo-planar image readout; T2-STIR  T2-weighted shostudy was not powered to determine whether this
effect is independent of other determinants of
ventricular function, such as infarct size and MO.
C O N C L U S I O N S
We conclude that T2*-CMR accurately detected
and quantified myocardial hemorrhage in vivo and
provides a tool to noninvasively investigate myocar-
dial hemorrhage as a novel diagnostic target in
myocardial reperfusion injury. Our data suggest
that hemorrhage occurs as a consequence of reper-
fusion in more advanced myocardial infarctions and
may therefore be a marker of more severe tissue
injury.
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